UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 3, 2017


(Exact name of registrant as specified in its charter)


Delaware
0-21121
06-1456680
(State or other jurisdiction of incorporation)
(Commission file number)
(I.R.S. employer identification no.)

One Hamden Center
 
2319 Whitney Ave, Suite 3B, Hamden, CT
06518
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code: (203) 859-6800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

Item 2.02 Results of Operations and Financial Condition.

The following information is being furnished pursuant to Item 2.02 "Results of Operations and Financial Condition" of Form 8-K.  Such information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

On May 3, 2017, TransAct issued a press release announcing its financial results for the quarter ending March 31, 2017.  A copy of the press release is furnished as Exhibit 99.1 to this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

Exhibit
Description
99.1
 
Press Release dated May 3, 2017 of TransAct Technologies Incorporated
 
 
 
 
 
 
 
 
 
 
 
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
TRANSACT TECHNOLOGIES INCORPORATED
   
By:
 
/s/Steven A. DeMartino
 
 
Steven A. DeMartino
 
 
President, Chief Financial Officer, Treasurer and Secretary

Date: May 3, 2017




TRANSACT TECHNOLOGIES REPORTS 2017 FIRST QUARTER RESULTS

Reports 2017 First Quarter Revenue of $14.0 Million and $0.13 GAAP Diluted EPS

Hamden, CT – May 3, 2017 – TransAct Technologies Incorporated (Nasdaq: TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and printing solutions for high-growth markets, today reported operating results for the first quarter ended March 31, 2017, as summarized below:

Summary of 2017 Q1 Results
(In millions, except per share and percentage data)

   
Three Months Ended
March 31,
 
   
2017
   
2016
 
Net sales
 
$
14.0
   
$
14.4
 
Gross profit
 
$
6.1
   
$
5.9
 
Gross margin
   
43.5
%
   
41.0
%
Operating income
 
$
1.4
   
$
0.9
 
Net income
 
$
0.9
   
$
0.6
 
Net income per diluted share
 
$
0.13
   
$
0.08
 
                 
Non-GAAP(1):
               
EBITDA
 
$
1.7
   
$
1.3
 
Adjusted EBITDA
 
$
1.9
   
$
1.4
 

(1)
A reconciliation of each non-GAAP financial measure to the most comparable Generally Accepted Accounting Principles ("GAAP")  financial measure can be found included with this release.  See "Non-GAAP Financial Measures" below for a discussion of these metrics.

Bart Shuldman, Chairman and Chief Executive Officer of TransAct, commented, "In the 2017 first quarter, we continued to benefit from the diversification of our business towards higher margin, higher value technology driven solutions. As a result, a 250 basis point year-over-year improvement in gross margin helped drive a 51% rise in net income, 63% growth in diluted EPS and a 36% increase in EBITDA.

"During the first quarter we made several adjustments to our planned investments in our AccuDate sales and marketing initiatives, which are now beginning this quarter.  We are working hard to build out our direct sales team for this market over the next several months.  In addition, to better align with and generate a higher impact from the NRA Show 2017, the major restaurant and foodservice industry convention taking place later this month, we also strategically delayed our direct marketing campaign to the second quarter.  This program is underway and we believe that by aligning it with the convention, we will drive a strong showing and higher market awareness for TransAct's AccuDate lineup.  We look forward to growing momentum over the balance of 2017 and in the future as a result of these investments, particularly as we better position our AccuDate offerings as the industry's best choice for in-kitchen technology solutions.
 
 

"TransAct improved the value proposition of our industry-leading AccuDate restaurant terminal solutions in the first quarter with the introduction of an important partnership with Jolt, which will bring their cloud-based restaurant management software platform to the AccuDate XL.  We believe this partnership will dramatically expand the market potential for our exciting new offering, complements our existing relationship with Crunchtime, which provides us with an innovative platform for food preparation, food management and other back-of-house processes.  Together, the software offerings further establish the AccuDate XL's valuable Android-based ecosystem, which makes our hardware offering unique in the restaurant and foodservice market today.  Importantly, we recently secured our first sale of the AccuDate XL with Jolt along with a service agreement that will provide us with a key new source of attractive, high-margin recurring revenue as the customer installs these terminals. Furthermore, we are also pleased that this sale opens up what we expect will be a significant new recurring revenue opportunity for TransAct in that this customer has also agreed to become the Company's first label customer as we launch our newest strategic initiative which we believe, over time will make TransAct a one-stop shop for most AccuDate labeling needs.

"Since its introduction in early 2016, the AccuDate XL has significantly elevated the market profile of our entire AccuDate restaurant solution product set.  Now comprised of the AccuDate 9700, PRO and XL, our range of solutions brings to restaurant and foodservice operators of all sizes a choice of fully customizable restaurant assistants.  These solutions can easily handle all the grab 'n go and food rotation labeling needs of any restaurant or foodservice operator while providing kitchen staffs with a powerful tool that can save money, greatly enhance operations and help grow their businesses.  The AccuDate 9700 and AccuDate PRO have successfully found their way into kitchens and many operators are now demonstrating considerable interest in the AccuDate XL, particularly given the recent integrations with Jolt and Crunchtime.

"Casino and gaming sales in the first quarter benefited from casino device printer shipments in support of a recent new property opening in the Pacific Northwest and both our casino and gaming and lottery markets remain healthy despite the ongoing maturation of these industries.  TransAct's Epic gaming and casino device printers and Epic lottery printers remain market share leaders in their respective industries as we continue to work with casino operators to help them appreciate the benefits that Epicentral can bring to their gaming floors."

Mr. Shuldman concluded, "During the first quarter we made significant progress toward strengthening our foundation for growth over the balance of the year as we begin to implement our sales and marketing programs to capture the significant potential of our restaurant solutions market while further benefiting from the stability of our casino and gaming and lottery operations.  TransAct remains focused on enhancing value for our shareholders in 2017 by taking advantage of the exciting opportunities in front of us."

Review of Balance Sheet and Capital Return Initiatives
As of March 31, 2017, TransAct had approximately $2.4 million of cash and cash equivalents and no debt.  During the 2017 first quarter, the Company paid a dividend to shareholders of $0.08 per share resulting in a total return of capital of $0.6 million for the quarter.  TransAct did not repurchase any shares of its common stock during the first quarter and continues to have $1.4 million remaining under its existing $5 million share repurchase authorization.


Steve DeMartino, President and Chief Financial Officer of TransAct, added, "Our healthy balance sheet continues to support our long-term growth initiatives, particularly our efforts to penetrate the meaningful market opportunity for our restaurant solutions.  In particular, we have begun to implement the previously announced marketing and sales investment initiatives related to this exciting opportunity and believe these efforts, including the hiring of an internal regional sales force and a highly targeted direct marketing initiative, will translate to increased sales later in 2017. TransAct remains debt free with a strong cash position and we are committed to the continued return of capital to shareholders, as evidenced by the 12.5% increase we recently announced in our quarterly dividend from $0.08 to $0.09 for the second quarter 2017.  We look forward to further growth in 2017 and expect to achieve additional progress against our growth initiatives over the balance of 2017 and beyond."

Summary of 2017 First Quarter Operating Results
TransAct generated 2017 first quarter net sales of $14.0 million compared with 2016 first quarter net sales of $14.4 million.  Restaurant solutions revenue declined to $0.5 million for the 2017 first quarter from $0.8 million for the 2016 first quarter, driven by lower sales to the Company's distributor and an ongoing shift in customer interest in the AccuDate XL following the recent Jolt software announcement. POS automation and banking increased $0.1 million year over year to $2.5 million in the 2017 first quarter reflecting continued strong shipments of Ithaca 9000 printers to McDonald's.  Casino and gaming revenue in the 2017 first quarter was $5.1 million compared to $5.4 million in the prior-year period, as strong domestic printer sales to support a new casino opening along with sales to support the healthy European off-premise sports betting market were more than offset by a decline in domestic Epicentral revenue and lower international gaming device printer sales.  Lottery printer sales in the 2017 first quarter were $3.0 million compared with $2.9 million in the 2016 first quarter.  Printrex revenues were $0.2 million in both the 2017 and 2016 first quarter periods, while the Company's TransAct Services Group generated net sales of $2.7 million in both the 2017 and 2016 first quarter periods.

Gross margin of 43.5% in the 2017 first quarter compared to gross margin of 41.0% in the 2016 first quarter, reflecting a favorable sales mix.  Higher gross margins in the 2017 first quarter more than offset the 3% decline in revenues, resulting in a 4% increase in gross profit to $6.1 million.

Total operating expenses for the 2017 first quarter were $4.7 million compared to $4.9 million in the year-ago quarter.  The decline in operating expenses reflects lower engineering expenses, as the 2016 first quarter included spending related to Epicentral software development and the build-out of the AccuDate product line, as well as lower selling and marketing expenses due to lower commissions and travel expenses.

TransAct generated operating income of $1.4 million for the 2017 first quarter compared to $0.9 million in the 2016 first quarter.  Net income in the 2017 first quarter was $0.9 million, or $0.13 per diluted share, compared to net income of $0.6 million, or $0.08 per diluted share, in the prior year period.

2017 First Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, May 3, 2017, beginning at 4:30 p.m. ET.  Both the call and the webcast are open to the general public.  The conference call number is 678-825-8259 and the conference ID number is 10012568 (domestic or international).  Please call five minutes prior to the presentation to ensure that you are connected.


Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select "Investor Relations" followed by "Events & Presentations").  Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.

Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these amounts are helpful to investors and others in assessing the ongoing nature of what the Company's management views as TransAct's core operations.  The Company believes that the non-GAAP financial measures of EBITDA and adjusted EBITDA provide relevant and useful information, which is widely used by analysts, investors and competitors in the Company's markets, as well as by the Company's management in assessing the Company's performance.  The Company uses the non-GAAP financial measures internally to focus management on the results of the Company's core business. The presentation of this additional non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.

EBITDA is defined as net income before net interest expense, income taxes, depreciation and amortization.  A reconciliation of EBITDA to net income, the most comparable GAAP financial measure, can be found attached to this release.

Adjusted EBITDA is defined as net income before net interest expense, income taxes, depreciation, and amortization and is adjusted for share-based compensation.  The Company adjusts EBITDA for share-based compensation as the Company considers share-based compensation to be a non-cash expense similar to depreciation and amortization, and believes that it provides investors with an additional measure of the Company's liquidity.  A reconciliation of adjusted EBITDA to net income, the most comparable GAAP financial measure, can be found attached to this release.

EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes.  EBITDA and adjusted EBITDA may be useful to an investor in evaluating the Company's operating performance and liquidity because this measure is: (i) widely used by investors to measure a company's operating performance without regard to non-recurring items excluded from the calculation of such measure; (ii) a financial measurement that is used by lenders and other parties to evaluate creditworthiness and liquidity; and (iii) used by the Company's management for various purposes including strategic planning and forecasting, assessing financial performance and liquidity, and paying incentive compensation.

About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing software-driven technology and printing solutions for high-growth markets including restaurant solutions, POS automation, casino and gaming, lottery, mobile and oil and gas. The Company's solutions are designed from the ground up based on customer requirements and are sold under the AccuDate™, EPICENTRAL®, Epic®, Ithaca®, RESPONDER and Printrex® brands. TransAct has over 3.0 million printers and terminals installed around the world and is committed to providing world-class service, spare parts and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.

Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe" or "continue" or the negative thereof or other similar words.  All forward-looking statements involve risks and uncertainties, including, but not limited to, customer acceptance and market share gains, both domestically and internationally, in the face of substantial competition from competitors that have broader lines of products and greater financial resources; our competitors introducing new products into the marketplace; our ability to successfully develop new products; our dependence on significant customers; our dependence on significant vendors; dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our ability to protect intellectual property; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States, including Australia, New Zealand, Europe, Latin America and Asia; the economic and political conditions in the United States, Australia, New Zealand, Europe, Latin America and Asia; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; risks associated with potential future acquisitions; our new line of food safety and oil and gas products driving increased adoption by customers; and other risk factors detailed from time to time in TransAct's reports filed with the Securities and Exchange Commission.  Actual results may differ materially from those discussed in, or implied by, the forward-looking statements.  The forward-looking statements speak only as of the date of this release and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.

# # #

Investor Contact:
Steve DeMartino
President and Chief Financial Officer
TransAct Technologies Incorporated
203-859-6810
Richard Land, Joseph Jaffoni, Jim Leahy
JCIR
212-835-8500 or tact@jcir.com
 

- Financial tables follow -


TRANSACT TECHNOLOGIES INCORPORATED
 
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
 
(Unaudited)
 
       
(In thousands, except per share amounts)
 
Three months ended
March 31,
 
   
2017
   
2016
 
Net sales
 
$
13,997
   
$
14,357
 
Cost of sales
   
7,904
     
8,472
 
Gross profit
   
6,093
     
5,885
 
                 
Operating expenses:
               
Engineering, design and product development
   
993
     
1,236
 
Selling and marketing
   
1,672
     
1,793
 
General and administrative
   
2,012
     
1,917
 
     
4,677
     
4,946
 
Operating income
   
1,416
     
939
 
                 
Interest and other income (expense):
               
Interest, net
   
(8
)
   
(4
)
Other, net
   
(6
)
   
1
 
     
(14
)
   
(3
)
                 
Income before income taxes
   
1,402
     
936
 
Income tax provision
   
459
     
311
 
Net income
 
$
943
   
$
625
 
                 
Net income per common share:
               
Basic
 
$
0.13
   
$
0.08
 
Diluted
 
$
0.13
   
$
0.08
 
                 
Shares used in per share calculation:
               
Basic
   
7,396
     
7,834
 
Diluted
   
7,445
     
7,883
 

SUPPLEMENTAL INFORMATION – SALES BY SALES UNIT:
 
   
Three months ended
March 31,
 
   
2017
   
2016
 
Restaurant solutions
 
$
527
   
$
822
 
POS automation and banking
   
2,458
     
2,315
 
Casino and gaming
   
5,117
     
5,438
 
Lottery
   
2,981
     
2,935
 
Printrex
   
178
     
155
 
TransAct services group
   
2,736
     
2,692
 
Total net sales
 
$
13,997
   
$
14,357
 



TRANSACT TECHNOLOGIES INCORPORATED
 
CONDENSED CONSOLIDATED BALANCE SHEETS
 
(Unaudited)
 
   
March 31,
   
December 31,
 
(In thousands)
 
2017
   
2016
 
Assets:
           
Current assets:
           
Cash and cash equivalents
 
$
2,429
   
$
2,503
 
Accounts receivable, net
   
9,304
     
10,585
 
Inventories, net
   
9,962
     
9,707
 
Other current assets
   
541
     
372
 
Total current assets
   
22,236
     
23,167
 
                 
Fixed assets, net
   
2,228
     
2,241
 
Goodwill
   
2,621
     
2,621
 
Deferred tax assets
   
3,410
     
3,432
 
Intangible assets, net
   
464
     
545
 
Other assets
   
37
     
36
 
     
8,760
     
8,875
 
Total assets
 
$
30,996
   
$
32,042
 
                 
Liabilities and Shareholders' Equity:
               
Current liabilities:
               
Accounts payable
 
$
3,556
   
$
4,894
 
Accrued liabilities
   
1,676
     
2,394
 
Income taxes payable
   
529
     
19
 
Deferred revenue
   
233
     
117
 
Total current liabilities
   
5,994
     
7,424
 
                 
Deferred revenue, net of current portion
   
67
     
67
 
Deferred rent, net of current portion
   
179
     
178
 
Other liabilities
   
260
     
264
 
     
506
     
509
 
Total liabilities
   
6,500
     
7,933
 
                 
Shareholders' equity:
               
Common stock
   
112
     
112
 
Additional paid-in capital
   
29,761
     
29,701
 
Retained earnings
   
24,482
     
24,157
 
Accumulated other comprehensive loss, net of tax
   
(107
)
   
(109
)
Treasury stock, at cost
   
(29,752
)
   
(29,752
)
Total shareholders' equity
   
24,496
     
24,109
 
Total liabilities and shareholders' equity
 
$
30,996
   
$
32,042
 
                 
 
 

TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
NON-GAAP FINANCIAL MEASURES
(Unaudited)
   
Three Months Ended
 
(In thousands)
 
March 31,
 
   
2017
   
2016
 
Net income
 
$
943
   
$
625
 
                 
Interest (income) expense, net
   
8
     
4
 
Income tax provision
   
459
     
311
 
Depreciation and amortization
   
313
     
324
 
                 
EBITDA
   
1,723
     
1,264
 
                 
Share-based compensation expense
   
146
     
145
 
                 
Adjusted EBITDA
 
$
1,869
   
$
1,409